Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 5;24(21):3990.
doi: 10.3390/molecules24213990.

Investigation of Potential Amorphisation and Co-Amorphisation Behaviour of the Benzene Di-Carboxylic Acids upon Cryo-Milling

Affiliations

Investigation of Potential Amorphisation and Co-Amorphisation Behaviour of the Benzene Di-Carboxylic Acids upon Cryo-Milling

Rehab Elfakhri et al. Molecules. .

Abstract

Multi-component formulations offer a way to modulate the physico-chemical properties of drug molecules and thereby enhance their efficacy as medicines compared to using only the raw drug, with mechano-chemical synthesis being an increasingly popular way to create these novel materials in a research setting. However, to date studies have focussed on employing pharmaceutically acceptable components, which has led to the literature featuring chemically diverse pairings of drug and excipient. Here we investigate the outcome of cryo-milling and co-cryo-milling of a series of three simple geometrical isomers of benzene di-carboxylic acid with a view to developing a chemically simple model system to investigate areas including cryo-milling, co-cryo-milling, co-amorphous formulation, etc. All three single-component materials exhibit differing behaviour upon cryo-milling and subsequent storage, as do the two-component mixtures. The surprisingly differing behaviours of these chemically similar species upon cryo-milling and co-cryo-milling suggest that molecular chemistry may not be the dominant influence on the outcome of mechano-chemical syntheses, and that other properties should be explored to develop a predictive model for the outcomes of these types of reactions.

Keywords: ATR-FTIR; DSC; XRPD; amorphous; co-amorphous; cryo-milling; formulation; mechanochemistry.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures of terephthalic acid (TPA), isophthalic acid (IPA) and phthalic acid (PA).
Figure 2
Figure 2
Differential Scanning Calorimetry (DSC) data for: (a) TPA; (b) IPA; and (c) PA. Exothermic up.
Figure 3
Figure 3
X-ray powder diffraction (XRPD) data for: (a) TPA; (b) IPA; and (c) PA, before and after cryo-milling and after storage at 43% relative humidity (RH) and room temperature for three weeks.
Figure 4
Figure 4
Attenuated Total Reflectance Infra-Red (ATR-FTIR) spectra for: TPA; IPA; and PA, as-received and after cryo-milling.
Figure 5
Figure 5
DSC data for co-cryo-milled combinations of (a) TPA, (b) IPA and (c) PA, with reference traces for the cryo-milled individual components at zero days also shown in red for reference. Exothermic up.
Figure 6
Figure 6
XRPD data for co-cryo-milled combinations of (a) TPA, (b) IPA and (c) PA as labelled. Red lines indicate the peak positions of the most intense peaks of the reference materials (freshly cryo-milled individual components) which are labelled “ref” and shown in red.
Figure 7
Figure 7
XRPD data for co-cryo-milled TPA/IPA, along with the predicted XRPD traces for the various TPA polymorphs.

References

    1. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins: Basic science and product development. J. Pharm. Pharmacol. 2010;11:1607–1621. doi: 10.1111/j.2042-7158.2010.01030.x. - DOI - PubMed
    1. Laitinen R., Lbmann K., Grohganz H., Priemel P., Strachan C.J., Rades T. Supersaturating drug delivery systems: The potential of co-amorphous drug formulations. Int. J. Pharm. 2017;532:1–12. doi: 10.1016/j.ijpharm.2017.08.123. - DOI - PubMed
    1. Bastin R.J., Bowker M.J., Slater B.J. Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities. Org. Process Res. Dev. 2000;4:427–435. doi: 10.1021/op000018u. - DOI
    1. Kumar L., Amin A., Bansal A.K. An overview of automated systems relevant in pharmaceutical salt screening. Drug Discov. Today. 2007;12:1046–1053. doi: 10.1016/j.drudis.2007.08.002. - DOI - PubMed
    1. Serajuddin A.T.M. Salt formation to improve drug solubility. Adv. Drug Deliv. Rev. 2007;59:603–616. doi: 10.1016/j.addr.2007.05.010. - DOI - PubMed

MeSH terms

LinkOut - more resources